CARISSA PARDEKOOPER: Open Payments
NPI 1063815017 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 27 payments from 12 companies in 2025. Trend: 2023 $168 · 2024 $0 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $315 |
| GENZYME CORPORATION | 3 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $94 |
| Arcutis Biotherapeutics, Inc. | 1 | $87 |
| Kerecis Limited | 1 | $52 |
| Amgen Inc. | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $39 |
| PFIZER INC. | 1 | $34 |
| Incyte Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $16 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, ILUMYA, Zoryve, Kerecis SurgiClose, OTEZLA, CIBINQO.
Industry payments across VA — which companies pay providers there.
